With 0.14 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.2 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.8488 whereas the lowest price it dropped to was $0.78. The 52-week range on TRIB shows that it touched its highest point at $3.55 and its lowest point at $0.75 during that stretch. It currently has a 1-year price target of $15.00. TRIB paid its most recent dividend on 1433462400, while the ex-dividend date for that was 1433462400. Beta for the stock currently stands at 1.03.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TRIB was down-trending over the past week, with a drop of -1.31%, but this was down by -7.98% over a month. Three-month performance dropped to -53.60% while six-month performance fell -73.18%. The stock lost -65.58% in the past year, while it has lost -6.16% so far this year. A look at the trailing 12-month EPS for TRIB yields -2.26 with Next year EPS estimates of -0.90. For the next quarter, that number is -0.30. This implies an EPS growth rate of 63.87% for this year and 48.28% for next year.
Float and Shares Shorts:
At present, 11.37 million TRIB shares are outstanding with a float of 10.96 million shares on hand for trading. On 2024-10-31, short shares totaled 94129.0, which was 99.00000000000001 higher than short shares on 1727654400. In addition to Mr. John Gillard as the firm’s President, CEO, Company Secretary & Director, Mr. Ronan O’Caoimh A.C.A. serves as its Founder, Director & Executive Advisor.
Institutional Ownership:
Through their ownership of 0.23959999 of TRIB’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, TRIB reported revenue of $15152000.0 and operating income of -$2219000.0. The EBITDA in the recently reported quarter was -$773000.0 and diluted EPS was -$0.46.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
Analysts have provided yearly estimates in a range of -$1.74 being high and -$1.74 being low. For TRIB, this leads to a yearly average estimate of -$1.74. Based on analyst estimates, the high estimate for the next quarter is -$0.28 and the low estimate is -$0.28. The average estimate for the next quarter is thus -$0.28.
